Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
By emphasizing the expanding therapeutic scope of GLP-1 beyond traditional metabolic targets, we elucidate the current evidence and potential mechanisms of GLP-1R agonists in neurological conditions other than PD and AD
Diabetes Med (2013) 30(8):893900
Q Dinh, R Sinclair
Metformin Metformin remains the foundational therapy for type 2 diabetes because of its long-standing efficacy, low cost, and extensive clinical history
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
US$ 26.56
US$ 21.48
US$ 25.63
US$ 28.82
US$ 24.47
US$ 29.49
US$ 21.28
US$ 26.84
